Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Merck
Baxter
AstraZeneca
Johnson and Johnson

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Litigation Details for Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS (D. Del. 2014)

See Plans and Pricing

« Back to Dashboard

Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS (D. Del. 2014)

Docket   Start Trial Date Filed 2014-02-14
Court District Court, D. Delaware Date Terminated 2015-07-09
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ALLEN M. -SM- TERRELL, JR.; MERCK SHARP & DOHME CORP.; XELLIA PHARMACEUTICALS APS; XELLIA PHARMACEUTICALS INC.
Patents 5,378,804; 5,466,823; 5,514,650; 5,563,165; 5,760,068; 5,952,300; 6,136,783
Attorneys Brian V. Slater; Carol M. Pitzel Cruz; Daniel R. Evans; Derek James Fahnestock; Jack B. Blumenfeld; Jeffrey D. Blake; Jeffrey S. Ward; Jeffrey Thomas Castellano; Karen Elizabeth Keller; Marcus A. Colucci; Stephen R. Howe; Wendy M. Ward; William R. Zimmerman
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-02-14 1 infections ll. Mel‘-ck is the owner of U.S.. Patent 'No. 5_,952,300 (“tlie ’_300 :p'atent’-’) (Attach… COMPLAINT FOR PATENT INFRINGEMENT - filed against Xellia Pharmaceuticals ApS. Magistrate Consent…PHARMAC_EUTIC-ALS APS,_ Defendant. cOMPLAIN'r F.oR 'PATENT MRINGEMENT math Merek sharp aa name o_arp. (heremaher…AND vENUE "7. This action arises under the patent laws of the Uni_ted _States of Arnelie'a. Thi-s…an embodiment of one or more claims of the .’300 patent Case 1:14-CV-00199-RGA Document 1 Filed 02/14/ External link to document
2015-06-29 101 U.S. Patent Nos. 5,466,823; 5,563,165… Searle’s European Patent 0697157 (the ″Searle ’157 Patent″); SHEILA F. MCSHANE, GIBBONS, …contained therein. European Patent Office by plaintiff Searle’s German patent Instead Pfizer… ’157 Patent. Teva argues that the briefs are not hearsay patents-in-suit. As above, the…submitted to the European Patent Office (i.e. DXT support its European patent application and then External link to document
2015-07-13 111 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,952,300. (Attachments: # 1 … 2014 9 July 2015 1:14-cv-00199 830 Patent None District Court, D. Delaware External link to document
2014-05-21 25 STIPULATION Regarding Patent No. 5,952,300, by Merck Sharp & Dohme Corp.. (Blumenfeld, Jack) Modified… 2014 9 July 2015 1:14-cv-00199 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
McKinsey
Express Scripts
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.